{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:24:58Z","timestamp":1787005498799,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1067\/mai.2002.126226","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T17:24:11Z","timestamp":1034184251000},"page":"189-198","source":"Crossref","is-referenced-by-count":57,"title":["Molecular virology and immunology of HIV infection"],"prefix":"10.1067","volume":"110","author":[{"given":"Javier","family":"Chinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Shearer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mai.2002.126226_bib1","first-page":"165","article-title":"Update on trends in AIDS incidence, deaths and prevalence\u2014United States, 1996","volume":"46","author":"Centers for Disease Control","year":"1997","journal-title":"MMWR"},{"key":"10.1067\/mai.2002.126226_bib2","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1097\/00002030-199910010-00017","article-title":"Natural history of HIV infection in the era of combination antiretroviral therapy","volume":"13","author":"Moore","year":"1999","journal-title":"AIDS"},{"key":"10.1067\/mai.2002.126226_bib3","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJM199905273402101","article-title":"Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy","volume":"340","author":"Zhang","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2002.126226_bib4","doi-asserted-by":"crossref","first-page":"23883","DOI":"10.1074\/jbc.270.41.23883","article-title":"The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection","volume":"270","author":"Freed","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1067\/mai.2002.126226_bib5","article-title":"Human immunodeficiency virus and its replication","author":"Luciw","year":"1996"},{"key":"10.1067\/mai.2002.126226_bib6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00002030-199905280-00002","article-title":"What role does HIV-1 subtype plays in transmission and pathogenesis? An epidemiological perspective","volume":"13","author":"Hu","year":"1999","journal-title":"AIDS"},{"key":"10.1067\/mai.2002.126226_bib7","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1128\/JVI.75.6.2993-3000.2001","article-title":"Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions","volume":"75","author":"Schaeffer","year":"2001","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/312763a0","article-title":"The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus","volume":"312","author":"Dalgleish","year":"1984","journal-title":"Nature"},{"key":"10.1067\/mai.2002.126226_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/312767a0","article-title":"T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV","volume":"312","author":"Klatzmann","year":"1984","journal-title":"Nature"},{"key":"10.1067\/mai.2002.126226_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0092-8674(00)81429-4","article-title":"Chemokine receptors: keys to AIDS pathogenesis","volume":"93","author":"Littman","year":"1998","journal-title":"Cell"},{"key":"10.1067\/mai.2002.126226_bib11","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1126\/science.280.5371.1884","article-title":"The HIV-1 envelope glycoproteins: fusogens, antigens and immunogens","volume":"280","author":"Wyatt","year":"1998","journal-title":"Science"},{"key":"10.1067\/mai.2002.126226_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/emboj\/20.1.19","article-title":"The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte surface","volume":"20","author":"Cladera","year":"2001","journal-title":"EMBO J"},{"key":"10.1067\/mai.2002.126226_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1126\/science.8356453","article-title":"Genotypic and phenotypic characterization of HIV-1 patients with primary infection","volume":"261","author":"Zhu","year":"1993","journal-title":"Science"},{"key":"10.1067\/mai.2002.126226_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0952-7915(97)80110-0","article-title":"Co-receptors for HIV-1 entry","volume":"9","author":"Moore","year":"1997","journal-title":"Curr Opinion Immunol"},{"key":"10.1067\/mai.2002.126226_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1126\/science.276.5309.51","article-title":"Coreceptors: implications for HIV pathogenesis and therapy","volume":"276","author":"Moore","year":"1997","journal-title":"Science"},{"key":"10.1067\/mai.2002.126226_bib16","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1128\/JVI.75.15.6776-6785.2001","article-title":"Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates","volume":"75","author":"Tokunaga","year":"2001","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00002030-200101260-00004","article-title":"Chemokine\/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals","volume":"15","author":"Nokta","year":"2001","journal-title":"AIDS"},{"key":"10.1067\/mai.2002.126226_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/83365","article-title":"Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor","volume":"7","author":"Saha","year":"2001","journal-title":"Nat Med"},{"key":"10.1067\/mai.2002.126226_bib19","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/3293","article-title":"Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry","volume":"4","author":"Kilby","year":"1998","journal-title":"Nat Med"},{"key":"10.1067\/mai.2002.126226_bib20","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1128\/JVI.75.11.5043-5048.2001","article-title":"Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1","volume":"75","author":"Cen","year":"2001","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/jmbi.1994.1665","article-title":"Locations of anti-AIDS drug binding sites and resistance mutations in the three dimensional structure of HIV-1 reverse transcriptase","volume":"243","author":"Tantillo","year":"1994","journal-title":"J Mol Biol"},{"key":"10.1067\/mai.2002.126226_bib22","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/bmj.322.7299.1410","article-title":"ABC of AIDS. Antiretroviral drugs","volume":"322","author":"Weller","year":"2001","journal-title":"BMJ"},{"key":"10.1067\/mai.2002.126226_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-1119(00)00583-7","article-title":"Cytoplasmic retention of HIV-1 regulatory protein Vpr by protein-protein interaction with a novel cytoplasmic protein VprBP","volume":"263","author":"Zhang","year":"2001","journal-title":"Gene"},{"key":"10.1067\/mai.2002.126226_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nm0497-389","article-title":"HIV accessory proteins as therapeutic targets","volume":"3","author":"Miller","year":"1997","journal-title":"Nat Med"},{"key":"10.1067\/mai.2002.126226_bib25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00002030-199601001-00002","article-title":"HIV cDNA integration: molecular biology and inhibitor development","volume":"10","author":"Farnett","year":"1996","journal-title":"AIDS"},{"key":"10.1067\/mai.2002.126226_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/384375a0","article-title":"Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain","volume":"384","author":"Parada","year":"1996","journal-title":"Nature"},{"key":"10.1067\/mai.2002.126226_bib27","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.280.5371.1880","article-title":"HIV-1 regulatory\/accessory genes: keys to unraveling viral and host cell biology","volume":"280","author":"Emerman","year":"1998","journal-title":"Science"},{"key":"10.1067\/mai.2002.126226_bib28","first-page":"S13","article-title":"Regulatory mechanisms involved in the control of HIV-1 expression","volume":"8","author":"Garcia","year":"1994","journal-title":"AIDS"},{"key":"10.1067\/mai.2002.126226_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/331280a0","article-title":"Characterization of ribosomal frame-shifting in HIV-1 gag-pol expression","volume":"231","author":"Jacks","year":"1988","journal-title":"Nature"},{"key":"10.1067\/mai.2002.126226_bib30","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1128\/JVI.75.12.5473-5481.2001","article-title":"The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process","volume":"75","author":"Tritel","year":"2001","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib31","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/JVI.72.3.2280-2288.1998","article-title":"CD4 glycoprotein degradation induced by human immunodeficiency virus type Vpu protein requires the function of proteosomes and the ubiquitin-conjugating pathway","volume":"72","author":"Schubert","year":"1998","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib32","doi-asserted-by":"crossref","first-page":"15920","DOI":"10.1074\/jbc.M010533200","article-title":"The human immunodeficiency virus type 1 Vpu protein inhibits NFkappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B","volume":"276","author":"Bour","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1067\/mai.2002.126226_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm0297-205","article-title":"Antiviral pressure exerted by HIV-1 specific cytotoxic T-lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus","volume":"3","author":"Borrow","year":"1997","journal-title":"Nat Med"},{"key":"10.1067\/mai.2002.126226_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nm0297-212","article-title":"Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS","volume":"3","author":"Goulder","year":"1997","journal-title":"Nat Med"},{"key":"10.1067\/mai.2002.126226_bib35","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.94.18.9848","article-title":"Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T-cell clones during primary HIV infection","volume":"94","author":"Pantaleo","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1067\/mai.2002.126226_bib36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1067\/mai.2000.105315","article-title":"gp120-and TNF-alpha induced modulation of human B cell function: proliferation, cyclic AMP generation, Ig production, and B-cell receptor expression","volume":"105","author":"Patke","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2002.126226_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI115621","article-title":"Human immunodeficiency virus infection induces both polyclonal and virus-specific B-cell activation","volume":"89","author":"Shirai","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1067\/mai.2002.126226_bib38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI112595","article-title":"Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders","volume":"78","author":"Yarchoan","year":"1986","journal-title":"J Clin Inv"},{"key":"10.1067\/mai.2002.126226_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/clin.1996.0176","article-title":"HIV disease in children is associated with a selective decrease in CD23 and CD62L B-cells","volume":"81","author":"Rodriguez","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1067\/mai.2002.126226_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0022-3476(05)80899-6","article-title":"Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first 4 years of life","volume":"120","author":"Borkowsky","year":"1992","journal-title":"J Pediatr"},{"key":"10.1067\/mai.2002.126226_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00006454-199502000-00009","article-title":"Antibody responses to Hemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection","volume":"14","author":"Gibb","year":"1995","journal-title":"Ped Infect Dis J"},{"key":"10.1067\/mai.2002.126226_bib42","doi-asserted-by":"crossref","first-page":"10362","DOI":"10.1073\/pnas.181347898","article-title":"HIV-1 induced phenotypic and functional perturbations of B cells in chronically infected individuals","volume":"98","author":"Moir","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1067\/mai.2002.126226_bib43","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.4049\/jimmunol.155.11.5151","article-title":"Mapping the Ig superantigen-binding site of HIV gp120","volume":"155","author":"Goodglick","year":"1995","journal-title":"J Immunol"},{"key":"10.1067\/mai.2002.126226_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0166-3542(89)90025-9","article-title":"Antibody-independent, complement-mediated enhancement of HIV-1-infection by mannosidase I and II inhibitors","volume":"11","author":"Montefiori","year":"1989","journal-title":"Antiviral Res"},{"key":"10.1067\/mai.2002.126226_bib45","first-page":"961","article-title":"Complement-mediated enhancement of HIV-1-infection of the monoblastoid cell line U937","volume":"4","author":"Reisinger","year":"1990","journal-title":"J Acquire Immune Def Synd"},{"key":"10.1067\/mai.2002.126226_bib46","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.4049\/jimmunol.166.5.3377","article-title":"Soluble CD16 inhibits CR3-mediated infection of monocytes\/macrophages by opsonized primary R5 HIV-1","volume":"166","author":"Bouhlal","year":"2001","journal-title":"J Immunol"},{"key":"10.1067\/mai.2002.126226_bib47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1034\/j.1600-065X.2001.1800115.x","article-title":"The supportive role of complement in HIV pathogenesis","volume":"180","author":"Stoiber","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1067\/mai.2002.126226_bib48","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1128\/JVI.75.14.6558-6565.2001","article-title":"Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1","volume":"75","author":"Schwarf","year":"2001","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib49","first-page":"S137","article-title":"The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity","volume":"13","author":"Parren","year":"1999","journal-title":"AIDS"},{"key":"10.1067\/mai.2002.126226_bib50","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 infection syndrome","volume":"68","author":"Koup","year":"1994","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib51","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00042560-199604150-00003","article-title":"Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads","volume":"11","author":"Pellegrin","year":"1996","journal-title":"J Acquir Immune Def Syndr Hum Retrovirol"},{"key":"10.1067\/mai.2002.126226_bib52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80043-6","article-title":"Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo","volume":"10","author":"Poignard","year":"1999","journal-title":"Immunity"},{"key":"10.1067\/mai.2002.126226_bib53","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/35073658","article-title":"Cellular immune responses to HIV","volume":"10","author":"McMichael","year":"2001","journal-title":"Nature"},{"key":"10.1067\/mai.2002.126226_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1067\/mai.2001.116573","article-title":"Decline of CD3 T-cell counts by six months of age is associated with rapid disease progression in HIV-1-infected infants","volume":"108","author":"Chinen","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2002.126226_bib55","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1006\/clin.1998.4577","article-title":"Decline in total T-cell count is associated with onset of AIDS, independent of CD4 lymphocyte count: implications for AIDS pathogenesis","volume":"88","author":"Margolick","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1067\/mai.2002.126226_bib56","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jama.279.10.756","article-title":"Predictive value of quantitative RNA and CD4 lymphocyte count for disease progression and response therapy in HIV-infected children","volume":"279","author":"Palumbo","year":"1998","journal-title":"JAMA"},{"key":"10.1067\/mai.2002.126226_bib57","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1086\/314868","article-title":"Early and persistent human immunodeficiency virus type-1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection","volume":"180","author":"Musey","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1067\/mai.2002.126226_bib58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/8400","article-title":"HIV-1-specific CD4+ T-cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression","volume":"5","author":"Pitcher","year":"1999","journal-title":"Nat Med"},{"key":"10.1067\/mai.2002.126226_bib59","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1 specific CD4+ T-cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"key":"10.1067\/mai.2002.126226_bib60","first-page":"S161","article-title":"Lymphocyte proliferative responses to HIV antigens as a potential measure of immune reconstitution in HIV disease","volume":"14","author":"Valentine","year":"1998","journal-title":"AIDS Res Human Retroviruses"},{"key":"10.1067\/mai.2002.126226_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/clin.1994.1046","article-title":"T-cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping","volume":"71","author":"Plaeger-Marshall","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1067\/mai.2002.126226_bib62","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/00002030-199611000-00004","article-title":"CD4 memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children","volume":"10","author":"Sleasman","year":"1996","journal-title":"AIDS"},{"key":"10.1067\/mai.2002.126226_bib63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nm0298-215","article-title":"Perturbation of CD4+ and CD8+ T-cell repertories during progression to AIDS and regulation of the CD4+ repertories during antiviral therapy","volume":"4","author":"Gorochov","year":"1998","journal-title":"Nat Med"},{"key":"10.1067\/mai.2002.126226_bib64","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm0597-533","article-title":"HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies","volume":"3","author":"Connors","year":"1997","journal-title":"Nat Med"},{"key":"10.1067\/mai.2002.126226_bib65","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/35073648","article-title":"The dynamics of CD4 T-cell depletion in HIV disease","volume":"410","author":"McCune","year":"2001","journal-title":"Nature"},{"key":"10.1067\/mai.2002.126226_bib66","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00126334-200008010-00010","article-title":"Model of HIV-1 disease prognosis based on virus-induced lymph node homing and homing-induced apoptosis of CD4 lymphocytes","volume":"24","author":"Kirschner","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/mai.2002.126226_bib67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/smim.1999.0169","article-title":"The importance of lymphocyte trafficking in regulating blood lymphocyte levels during HIV and SIV infections","volume":"11","author":"Rosenberg","year":"1999","journal-title":"Sem Immunol"},{"key":"10.1067\/mai.2002.126226_bib68","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.72.12.10108-10117.1998","article-title":"CCR5 and CXR4 strain of HIV-1 exhibit differential tropism and pathogenesis in vivo","volume":"172","author":"Berkowitz","year":"1998","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/1074-7613(95)90076-4","article-title":"HIV-1 induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo","volume":"2","author":"Su","year":"1995","journal-title":"Immunity"},{"key":"10.1067\/mai.2002.126226_bib70","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","article-title":"DC-SIGN, a dendritic cell specific HIV-1 binding protein that enhances trans-infection of T-cells","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"10.1067\/mai.2002.126226_bib71","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"key":"10.1067\/mai.2002.126226_bib72","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8+ T-cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"Jin","year":"1999","journal-title":"J Exp Med"},{"key":"10.1067\/mai.2002.126226_bib73","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/370463a0","article-title":"Major expansion of CD8 T-cells with a predominant Vb usage during the primary response of HIV","volume":"370","author":"Pantaleo","year":"1994","journal-title":"Nature"},{"key":"10.1067\/mai.2002.126226_bib74","first-page":"904","article-title":"Elevated levels of CD38 CD8 T cells add to the prognostic value of low CD4 T cell levels: results of 6 years of follow up","volume":"6","author":"Giorgi","year":"1993","journal-title":"J AIDS"},{"key":"10.1067\/mai.2002.126226_bib75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1067\/mai.2001.117179","article-title":"Comparison of CD8+ T-cell subsets in HIV-infected rapid progressor children vs non-rapid progressor children","volume":"108","author":"Paul","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2002.126226_bib76","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1172\/JCI115153","article-title":"CD8 cell anti HIV activity correlates with the clinical state of the infected individuals","volume":"87","author":"Mackewicz","year":"1991","journal-title":"J Clin Inv"},{"key":"10.1067\/mai.2002.126226_bib77","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.181.4.1365","article-title":"Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics","volume":"181","author":"Klein","year":"1995","journal-title":"J Exp Med"},{"key":"10.1067\/mai.2002.126226_bib78","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"Borrow","year":"1994","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib79","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1126\/science.279.5359.2103","article-title":"Quantitation of HIV-1 specific cytotoxic T-lymphocytes and plasma load of viral RNA","volume":"279","author":"Ogg","year":"1998","journal-title":"Science"},{"key":"10.1067\/mai.2002.126226_bib80","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1086\/514013","article-title":"Human immunodeficiency virus type-1 specific cytotoxic T lymphocytes (CTL) viral load, and CD4 T-cell loss: evidence supporting a protective role for CTL in vivo","volume":"176","author":"Greenough","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1067\/mai.2002.126226_bib81","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.4049\/jimmunol.165.2.1082","article-title":"Maintenance of large numbers of virus-specific CD8 T-cells in HIV-infected progressors and non-progressors","volume":"165","author":"Gea-Banacloche","year":"2000","journal-title":"J Immunol"},{"key":"10.1067\/mai.2002.126226_bib82","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1128\/JVI.74.2.1018-1022.2000","article-title":"Human immunodeficiency virus type1- and cytomegalovirus-specific cytotoxic T-lymphocytes can persist at high frequency for pro-olonged periods in the absence of circulating peripheral CD4+ T cells","volume":"74","author":"Spiegel","year":"2000","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/1521-4141(200001)30:1<117::AID-IMMU117>3.0.CO;2-4","article-title":"Association between HIV-specific T helper responses and CTL activities in pediatric AIDS","volume":"30","author":"Wasik","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1067\/mai.2002.126226_bib84","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO;2-M","article-title":"High viral burden in the presence of major HIV-specific CD8+ T-cell expansions: evidence for impaired CTL effector function","volume":"31","author":"Kostense","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1067\/mai.2002.126226_bib85","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.192.1.63","article-title":"HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function","volume":"192","author":"Appay","year":"2000","journal-title":"J Exp Med"},{"key":"10.1067\/mai.2002.126226_bib86","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0198-8859(95)00034-8","article-title":"Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: a review of the literature examining associations with HLA","volume":"44","author":"Just","year":"1995","journal-title":"Hum Immunol"},{"key":"10.1067\/mai.2002.126226_bib87","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.4049\/jimmunol.162.11.6942","article-title":"New Class I and Class II HLA alleles strongly associate with opposite patterns of progression to AIDS","volume":"162","author":"Hendel","year":"1999","journal-title":"J Immunol"},{"key":"10.1067\/mai.2002.126226_bib88","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm0496-405","article-title":"Influence of combinations of human major histocompatibility complex genes on the course of HIV infection","volume":"2","author":"Kaslow","year":"1996","journal-title":"Nat Med"},{"key":"10.1067\/mai.2002.126226_bib89","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/318092","article-title":"The HLA A2\/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission","volume":"183","author":"MacDonald","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1067\/mai.2002.126226_bib90","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJM200105313442203","article-title":"Effect of a single amino acid change in MHC Class I molecules in the rate of progression to AIDS","volume":"344","author":"Gao","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2002.126226_bib91","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/aid.1996.12.1053","article-title":"Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection","volume":"12","author":"Clerici","year":"1996","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1067\/mai.2002.126226_bib92","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1089\/aid.1996.12.1141","article-title":"Differential production of interleukin 10 during human immunodeficiency virus infection","volume":"12","author":"Chehimi","year":"1996","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1067\/mai.2002.126226_bib93","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.4049\/jimmunol.145.12.4059","article-title":"Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases","volume":"145","author":"Honda","year":"1990","journal-title":"J Immunol"},{"key":"10.1067\/mai.2002.126226_bib94","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4049\/jimmunol.141.1.99","article-title":"Spontaneous cytotoxity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients","volume":"141","author":"Wright","year":"1988","journal-title":"J Immunol"},{"key":"10.1067\/mai.2002.126226_bib95","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.179.4.1361","article-title":"Impaired interleukin 12 production in human immunodeficiency virus-infected patients","volume":"179","author":"Chehimi","year":"1994","journal-title":"J Exp Med"},{"key":"10.1067\/mai.2002.126226_bib96","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/infdis\/175.1.47","article-title":"Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children","volume":"175","author":"Than","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1067\/mai.2002.126226_bib97","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-3083.1997.d01-98.x","article-title":"Clinical progression of HIV infection: role of NK cells","volume":"46","author":"Bruunsgaard","year":"1997","journal-title":"Scan J Immunol"},{"key":"10.1067\/mai.2002.126226_bib98","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI11481","article-title":"Leukemia inhibitor factor inhibits HIV-1 replication and is upregulated in placenta from nontransmitting women","volume":"107","author":"Patterson","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1067\/mai.2002.126226_bib99","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood.V98.7.2166","article-title":"Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4+CD8-CD3+ thymocytes through sustained induction of bcl-2","volume":"98","author":"Guillemard","year":"2001","journal-title":"Blood"},{"key":"10.1067\/mai.2002.126226_bib100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nm0496-412","article-title":"Relative resistance to HIV-1 infection of CD4 lymphocytes despite multiple high-risk exposures","volume":"2","author":"Paxton","year":"1996","journal-title":"Nat Med"},{"key":"10.1067\/mai.2002.126226_bib101","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1097\/00002030-200110190-00005","article-title":"CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection, yet not sustained replication in Th1 and Th2 cells","volume":"15","author":"Moonis","year":"2001","journal-title":"AIDS"},{"key":"10.1067\/mai.2002.126226_bib102","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1alpha, MIP-1beta as the major HIV-1 suppressive factors produced by CD8 T-cells","volume":"270","author":"Cocchi","year":"1996","journal-title":"Science"},{"key":"10.1067\/mai.2002.126226_bib103","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/382833a0","article-title":"The CXC chemokine SDF-1 is the ligand for LESTR\/fusin and prevents infection by T-cell line adapted HIV-1","volume":"382","author":"Oberlin","year":"1996","journal-title":"Nature"},{"key":"10.1067\/mai.2002.126226_bib104","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/514192","article-title":"Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1 beta are associated with a decreased risk of HIV disease progression","volume":"133","author":"Ullum","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1067\/mai.2002.126226_bib105","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.4049\/jimmunol.162.7.4355","article-title":"Protective role of b-chemokines associated with HIV-specific Th responses against perinatal HIV transmission","volume":"162","author":"Wasik","year":"1999","journal-title":"J Immunol"},{"key":"10.1067\/mai.2002.126226_bib106","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0952-7915(00)00246-6","article-title":"Vaccines for prevention of HIV disease","volume":"13","author":"Mascola","year":"2001","journal-title":"Curr Opinion Immunol"},{"key":"10.1067\/mai.2002.126226_bib107","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/JVI.74.1.371-378.2000","article-title":"Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replication particles","volume":"74","author":"Davis","year":"2000","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib108","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1128\/JVI.73.9.7430-7440.1999","article-title":"Factors associated with slow-disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251","volume":"73","author":"Buge","year":"1999","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib109","doi-asserted-by":"crossref","first-page":"9485","DOI":"10.1128\/JVI.73.11.9485-9495.1999","article-title":"Mucosal immunization of cynomolgus macaques with two serotypes of life poliovirus vectors expressing simian immunodeficiency virus antigens: stimulation of humoral, mucosal and cellular immunity","volume":"73","author":"Crotty","year":"1999","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib110","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1128\/JVI.72.2.1552-1576.1998","article-title":"Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines","volume":"72","author":"Connor","year":"1998","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib111","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1128\/JVI.74.6.2584-2593.2000","article-title":"Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment","volume":"74","author":"Lifson","year":"2000","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib112","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1172\/JCI4314","article-title":"Cytotoxic T-cell responses to multiple conserved HIV epitopes in HIV resistant prostitutes in Nairobi","volume":"102","author":"Rowland-Jones","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1067\/mai.2002.126226_bib113","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/JVI.73.1.618-630.1999","article-title":"Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen","volume":"73","author":"Polacino","year":"1999","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib114","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/JVI.74.6.2502-2509.2000","article-title":"Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge","volume":"74","author":"Seth","year":"2000","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib115","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1089\/088922201316912781","article-title":"HIV type 1 vaccine-induced T cells memory and cytotoxic T lymphocyte responses in HIV type-1 uninfected volunteers","volume":"17","author":"Gorse","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1067\/mai.2002.126226_bib116","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/08892220050042846","article-title":"A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk of acquiring HIV type 1 infection","volume":"16","author":"McElrath","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1067\/mai.2002.126226_bib117","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/318523","article-title":"Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag and Pro in combination with rgp120","volume":"183","author":"Team TAVEGP","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1067\/mai.2002.126226_bib118","doi-asserted-by":"crossref","first-page":"10025","DOI":"10.1128\/JVI.74.21.10025-10033.2000","article-title":"A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4- R5-and dual-tropic clade B and C primary isolates","volume":"74","author":"Verrier","year":"2000","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib119","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.75.5.2224-2234.2001","article-title":"Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous simian\/human immunodeficiency virus infection in pigtailed macaques","volume":"75","author":"Cho","year":"2001","journal-title":"J Virol"},{"key":"10.1067\/mai.2002.126226_bib120","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0264-410X(99)00388-6","article-title":"A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120w61D derived from dual tropic R5X4 HIV-1ACH 320","volume":"18","author":"McCormack","year":"2000","journal-title":"Vaccine"},{"key":"10.1067\/mai.2002.126226_bib121","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1126\/science.290.5491.486","article-title":"Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination","volume":"290","author":"Barouch","year":"2000","journal-title":"Science"},{"key":"10.1067\/mai.2002.126226_bib122","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1086\/315229","article-title":"Vaccination of seronegative volunteers with a human immunodeficiency virus type1 env\/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta chemokines","volume":"181","author":"Boyer","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1067\/mai.2002.126226_bib123","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1096\/fasebj.11.10.9271360","article-title":"Genetic immunization: a new era of vaccines and immuno therapeutics","volume":"11","author":"Chattergoon","year":"1997","journal-title":"FASEB J"},{"key":"10.1067\/mai.2002.126226_bib124","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1128\/JVI.75.16.7621-7628.2001","article-title":"Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells","volume":"75","author":"Lisziewicz","year":"2001","journal-title":"J Virol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674902000799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674902000799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T04:45:45Z","timestamp":1682311545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674902000799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0091674902000799"],"URL":"https:\/\/doi.org\/10.1067\/mai.2002.126226","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}